首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1554259

消融設備市場規模、佔有率、成長分析：按產品、按應用、按最終用途、按地區 - 行業預測，2024-2031 年

Ablation Devices Market Size, Share, Growth Analysis, By Product, By Application, By End use, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月07日 | 出版商:

SkyQuest | 英文 265 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球消融設備市場規模為79.2億美元，從2023年的86億美元成長到2031年的179.2億美元，預計複合年成長率為8.5%。

手術技術在全球範圍內經歷了重大發展，醫療保健領域也取得了重大進展。這些進步包括採用最先進的篩檢、診斷和治療技術，以及引入盡量減少術後不適的策略。該領域的一個顯著發展是微創手術的興起，由於其優勢而變得越來越受歡迎。隨著人口老化的成長和慢性疾病變得更加複雜，患者正在尋求負擔較輕的治療方法。微創手術的好處包括減輕疼痛、縮短住院時間和加快復原時間。微創手術的重點是消融，這是一種透過汽化、冷凍、輻射和機械侵蝕等方法從人體器官中去除生物材料的技術。在醫療實踐中，消融通常用於以微創方式去除小腫瘤或污染組織。化學消融和射頻消融術等技術也用於瞄準和去除受影響的組織。消融術最近越來越受歡迎，因為它比傳統的開放性手術侵入性更小，並且為切除腫瘤和組織提供了更舒適的選擇。由於癌症和心血管疾病等慢性疾病的增加，預計對消融設備的需求將會成長。

市場概況
射頻設備
雷射/光學燒蝕機
- 準分子雷射燒蝕機
- 冷雷射燒蝕機
超音波設備
- 高強度聚焦超音波消融儀
- 體外震波碎石系統
- 磁振造影引導聚焦超音波消融裝置
冷凍消融裝置
- 組織接觸探頭
- 組織噴霧探針
- 表皮及皮下凍融裝置
電燒灼
- 氬離子/束凝固設備
- 不可逆電穿孔消融儀
微波消融儀
熱液消融器
其他

消融設備市場：依應用分類

市場概況
心血管疾病的治療
整容整形外科
整形外科治療
癌症治療
- 肝癌
- 腎癌
- 攝護腺癌
- 肺癌
- 骨轉移
- 乳癌
泌尿系統治療
婦科治療
疼痛管理
眼科治療

消融設備市場：依最終用途分類

市場概況
醫院、外科中心、消融中心
門診手術中心
醫療水療美容診所
其他最終用途

消融設備市場：按地區

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Johnson & Johnson（US）
Medtronic（Ireland）
Boston Scientific Corporation（US）
Abbott（US）
AtriCure, Inc.（US）
AngioDynamics（US）
ConMed Corporation（US）
Olympus Corporation（Japan）
Smith+Nephew（UK）
Stryker（US）
Cynosure Lutronic（US）
BioVentus（US）
Merit Medical Systems（US）
Canyon Medical Inc.（US）
Arthrex, Inc.（US）
IceCure Medical（Israel）
Minimax Medical Holding Group（China）
CardioFocus（US）
EDAP TMS（France）
Mermaid Medical（Denmark）
Monteris（Canada）
SonaBlate Corp.（US）
Eco Medical（US）
Surgnova（France）

簡介目錄

Product Code: SQMIG35A2603

Global Ablation Devices Market size was valued at USD 7.92 billion in 2022 and is poised to grow from USD 8.60 billion in 2023 to USD 17.92 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

Surgical techniques have undergone significant evolution globally, with substantial advancements in the healthcare sector. These advancements range from adopting cutting-edge screening, diagnostic, and treatment technologies to implementing strategies that minimize post-surgical discomfort. A notable development in this area is the rise of minimally invasive surgery, which has become increasingly favored due to its benefits. As the senior population grows and chronic conditions become more complex, patients are seeking less disruptive treatment options. Minimally invasive surgery offers advantages such as reduced pain, shorter hospital stays, and faster recovery times. A key aspect of minimally invasive procedures is ablation, a technique used to remove biological material from human organs through methods like vaporization, freezing, radiation, or mechanical erosion. In medical practice, ablation is typically employed to excise small tumors or contaminated tissues with minimal invasiveness. Techniques such as chemical ablation and radiofrequency ablation are also utilized to target and eliminate affected biological tissues. The popularity of ablation has surged recently due to its less intrusive nature compared to traditional open surgeries, offering a more comfortable alternative for tumor and tissue removal. With the increasing incidence of chronic diseases, including cancer and cardiovascular issues, the demand for ablation devices is expected to grow.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ablation Devices Market Segmental Analysis

The global Ablation Devices market is segmented based on product, application, end use, and region. Based on product, the market is segmented into Radiofrequency Devices, Laser/Light Ablators, Ultrasound Devices, Cryoablation Devices, Electric Ablators, Microwave Ablators, Hydrothermal Ablators and Others. Based on application, the market is segmented into Cardiovascular Disease Treatment, Cosmetic/Aesthetic Surgery, Orthopaedic Treatment, Cancer Treatment, Urological Treatment, Gynaecological Treatment, Pain Managment, and Ophthalmological Treatment. Based on end use, the market is segmented into Hospitals, Surgical Centers, And Ablation Centers, Ambulatory Surgical Centers, Medical Spas & Aesthetic Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, and MEA.

Drivers of the Global Ablation Devices Market

A significant driver of market growth is the increasing patient preference for minimally invasive procedures over traditional open surgeries. The popularity of minimally invasive treatments has surged due to their advantages, including shorter hospital stays, quicker recovery, and reduced discomfort compared to conventional methods. Additionally, the growing prevalence of atrial fibrillation among the general population is expected to drive the demand for cardiac ablation procedures. Minimally invasive ablation techniques for atrial fibrillation offer high effectiveness, lower risk, and greater patient convenience. Consequently, the growing adoption of less invasive treatment options and advancements in ablation devices are anticipated to significantly boost the ablation devices market in the coming years.

Restraints in the Global Ablation Devices Market

A notable limitation in the market is the absence of effective conventional first-line treatments for conditions such as liver cancer, uterine fibroids, hemorrhagic stroke, and other hemorrhagic disorders. Traditional therapies, including surgery, chemotherapy, and radiation, remain popular due to widespread public familiarity and acceptance. In particular, there is low adoption of newer treatment options in developing countries, coupled with oncologists' hesitation to move away from established methods. This reluctance to embrace advanced treatments impedes the growth of newer therapeutic approaches in these areas.

Market Trends of the Global Ablation Devices Market

Emerging markets in Asia-Pacific, Africa, and Latin America are anticipated to become increasingly attractive due to advancements in ablation technologies, rising demand for minimally invasive treatments, and growing disposable incomes. Additionally, these regions benefit from a substantial population with undiagnosed conditions, rapid urbanization leading to higher chronic disease rates, increased awareness of prostate cancer, and improved government funding for healthcare. These factors are expected to drive market growth and expand opportunities for ablation technologies in these regions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Value Chain Analysis
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Pest Analysis
Porter's Five Forces Analysis
Supply chain analysis
Ecosystem coverage: parent market
Reimbursement scenario
Pricing trend analysis
Trade Analysis

Global Ablation Devices Market by Product

Market Overview
Radiofrequency Devices
Laser/Light Ablators
- Excimer laser ablators
- Cold laser ablators
Ultrasound Devices
- High-intensity focused ultrasound ablators
- Extracorporeal shockwave lithotripsy systems
- Magnetic resonance-guided focused ultrasound ablators
Cryoablation Devices
- Tissue contacts probes
- Tissue spray probes
- Epidermal & subcutaneous cryoablation devices
Electric Ablators
- Argon plasma/beam coagulators
- Irreversible electroporation ablators
Microwave Ablators
Hydrothermal Ablators
Others

Global Ablation Devices Market by Application

Market Overview
Cardiovascular Disease Treatment
Cosmetic/Aesthetic Surgery
Orthopaedic Treatment
Cancer Treatment
- Liver Cancer
- Kidney Cancer
- Prostate Cancer
- Lung Cancer
- Bone Metastasis
- Breast Cancer
Urological Treatment
Gynaecological Treatment
Pain Managment
Ophthalmological Treatment

Global Ablation Devices Market by End Use

Market Overview
Hospitals, Surgical Centers, And Ablation Centers
Ambulatory Surgical Centers
Medical Spas & Aesthetic Clinics
Other End Users

Global Ablation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConMed Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cynosure Lutronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioVentus (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canyon Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IceCure Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minimax Medical Holding Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardioFocus (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EDAP TMS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mermaid Medical (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monteris (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonaBlate Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eco Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Surgnova (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments